1. 1. Abi-Gerges, N., Eschenhagen, T., Hove-Hadsen, L., Fischmeister, R. and Mery, P.F. 1997. Methylene blue is a muscarinic antagonist in cardiac myocytes. Mol. Pharmacol. 52: 482–490.
2. 2. Alvarez, P. A. and Pahissa, J. 2010. QT alterations in psychopharmacology: proven candidates and suspects. Curr. Drug Saf. 5: 97–104.
3. 3. Baldessarini, R. J. 2006. Drug therapy of depression and anxiety disorders. pp. 429–459. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th ed. (Brunton, L., Lazo, J., Parker, K., Buxton, I. and Blumenthal, D. eds.), McGraw-Hill, New York.
4. 4. Baldessarini, R. J. and Tarazi, F. I. 2006. Pharmacotherapy of psychosis and mania. pp. 461–500. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th ed. (Brunton, L., Lazo, J., Parker, K., Buxton, I. and Blumenthal, D. eds.), McGraw-Hill, New York.
5. Uncoupling of cardiac muscarinic and β-adrenergic receptors from ion channels by a guanine nucleotide analogue